PMC:7170368 / 9958-11712
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
308 | 61-75 | Gene | denotes | Angiotensin II | Gene:183 |
309 | 133-147 | Gene | denotes | Angiotensin II | Gene:183 |
310 | 307-321 | Gene | denotes | Angiotensin II | Gene:183 |
311 | 410-414 | Gene | denotes | AT1R | Gene:185 |
312 | 874-878 | Gene | denotes | IL-6 | Gene:3569 |
313 | 37-45 | Species | denotes | patients | Tax:9606 |
314 | 96-102 | Species | denotes | people | Tax:9606 |
315 | 281-289 | Species | denotes | patients | Tax:9606 |
316 | 511-519 | Species | denotes | patients | Tax:9606 |
317 | 579-587 | Species | denotes | patients | Tax:9606 |
318 | 721-729 | Species | denotes | patients | Tax:9606 |
319 | 1001-1009 | Species | denotes | patients | Tax:9606 |
320 | 962-965 | Chemical | denotes | LPS | MESH:D008070 |
321 | 1425-1433 | Chemical | denotes | ACEI/ARB | |
322 | 28-36 | Disease | denotes | COVID-19 | MESH:C000657245 |
323 | 163-175 | Disease | denotes | hypertension | MESH:D006973 |
324 | 180-192 | Disease | denotes | lung failure | MESH:D012131 |
325 | 268-277 | Disease | denotes | mortality | MESH:D003643 |
326 | 295-301 | Disease | denotes | sepsis | MESH:D018805 |
327 | 502-510 | Disease | denotes | COVID-19 | MESH:C000657245 |
328 | 570-578 | Disease | denotes | COVID-19 | MESH:C000657245 |
329 | 712-720 | Disease | denotes | COVID-19 | MESH:C000657245 |
330 | 735-747 | Disease | denotes | hypertension | MESH:D006973 |
331 | 974-990 | Disease | denotes | pneumonic injury | MESH:D011014 |
332 | 1015-1036 | Disease | denotes | chronic heart failure | MESH:D006333 |
333 | 1382-1393 | Disease | denotes | lung injury | MESH:D055370 |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32228222-31838905-27780685 | 303-304 | 31838905 | denotes | 9 |
32228222-31805278-27780686 | 992-994 | 31805278 | denotes | 11 |
32228222-15067208-27780687 | 1167-1169 | 15067208 | denotes | 12 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T27 | 180-184 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T28 | 374-383 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
T29 | 461-470 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
T30 | 1023-1028 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T31 | 1113-1121 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T32 | 1146-1154 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T33 | 1250-1263 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
T34 | 1289-1293 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T35 | 1382-1386 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T27 | 180-184 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T28 | 207-210 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
T29 | 621-624 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
T30 | 1023-1028 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T31 | 1250-1263 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
T32 | 1382-1386 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T33 | 1492-1495 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T88 | 28-36 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T89 | 163-175 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T90 | 502-510 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T91 | 570-578 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T92 | 712-720 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T93 | 735-747 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T94 | 786-789 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T95 | 939-942 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T96 | 984-990 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T97 | 1023-1036 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T98 | 1207-1210 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T99 | 1387-1393 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T100 | 1430-1433 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T86 | 180-184 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T87 | 180-184 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T88 | 396-406 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T89 | 677-680 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T90 | 992-994 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T91 | 1023-1028 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T92 | 1023-1028 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T93 | 1023-1028 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T94 | 1023-1028 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T95 | 1041-1044 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T96 | 1223-1224 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T97 | 1250-1263 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
T98 | 1287-1293 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
T99 | 1382-1386 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T100 | 1382-1386 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T102 | 61-75 | Chemical | denotes | Angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719 |
T103 | 73-75 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T104 | 133-147 | Chemical | denotes | Angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719 |
T105 | 145-147 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T106 | 207-210 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T107 | 211-221 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T108 | 307-321 | Chemical | denotes | Angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719 |
T109 | 319-321 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T110 | 595-600 | Chemical | denotes | ACEIs | http://purl.obolibrary.org/obo/CHEBI_35457 |
T111 | 621-624 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T112 | 874-876 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T114 | 962-965 | Chemical | denotes | LPS | http://purl.obolibrary.org/obo/CHEBI_16412|http://purl.obolibrary.org/obo/CHEBI_52603|http://purl.obolibrary.org/obo/CHEBI_89981 |
T117 | 1492-1495 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T118 | 1496-1506 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T119 | 1580-1589 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 813-834 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory response |
T3 | 1146-1165 | http://purl.obolibrary.org/obo/GO_0001816 | denotes | cytokine production |
T4 | 1523-1548 | http://purl.obolibrary.org/obo/GO_1903901 | denotes | inhibit viral replication |
T5 | 1531-1548 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
T6 | 1531-1548 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
T7 | 1629-1671 | http://purl.obolibrary.org/obo/GO_0050728 | denotes | inhibiting inflammatory responses, and the |
T8 | 1640-1662 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory responses |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T84 | 0-107 | Sentence | denotes | Studies have suggested that COVID-19 patients have increased Angiotensin II compared to healthy people [8]. |
T85 | 108-193 | Sentence | denotes | The abnormal increase in Angiotensin II was related to hypertension and lung failure. |
T86 | 194-306 | Sentence | denotes | In addition, RAS inhibitors have been shown to be associated with reduced mortality in patients with sepsis [9]. |
T87 | 307-420 | Sentence | denotes | Angiotensin II positively regulates the expression of inflammatory cytokines through the activation of AT1R [10]. |
T88 | 421-520 | Sentence | denotes | Excessively high levels of inflammatory cytokines are harmful to the outcomes of COVID-19 patients. |
T89 | 521-625 | Sentence | denotes | Thus, it was suggested that it is beneficial for COVID-19 patients to use ACEIs/ARBs to inhibit the RAS. |
T90 | 626-696 | Sentence | denotes | However, until now, no confirmed clinical evidence has been available. |
T91 | 697-996 | Sentence | denotes | In this study, COVID-19 patients with hypertension were enrolled, and we found that ACEI/ARB therapy attenuated the inflammatory response, potentially through the inhibition of IL-6 levels, which is consistent with the findings that ACEI and ARB therapy alleviated LPS-induced pneumonic injury [11]. |
T92 | 997-1171 | Sentence | denotes | For patients with chronic heart failure, it has been proven that ACEI therapy was associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production [12]. |
T93 | 1172-1304 | Sentence | denotes | This study also suggests that ACEI/ARB therapy had a beneficial effect on the immune system by avoiding peripheral T cell depletion. |
T94 | 1305-1398 | Sentence | denotes | Furthermore, the viral load was reported to be highly correlated with severe lung injury [8]. |
T95 | 1399-1754 | Sentence | denotes | It was also observed that ACEI/ARB therapy decreased the viral load, but we hypothesize that RAS inhibitors do not directly inhibit viral replication; rather, they play an indirect antiviral role by regulating immune function and inhibiting inflammatory responses, and the mechanism needs to be clarified through in vitro and in vivostudies in the future. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T24 | 163-175 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T25 | 295-301 | Phenotype | denotes | sepsis | http://purl.obolibrary.org/obo/HP_0100806 |
T26 | 735-747 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T27 | 1015-1036 | Phenotype | denotes | chronic heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32228222-31838905-27780685 | 303-304 | 31838905 | denotes | 9 |
32228222-31805278-27780686 | 992-994 | 31805278 | denotes | 11 |
32228222-15067208-27780687 | 1167-1169 | 15067208 | denotes | 12 |